by Maria Zannes | Jul 8, 2016 | News
JULY 8, 2016 As published in the San Antonio Business Journal By W. Scott Bailey San Antonio’s bioAffinity Technologies Inc. has hired a senior executive with strong ties to the city’s bioscience industry to help lead its new subsidiary — OncoSelect...
by Maria Zannes | Jul 7, 2016 | Press Releases
JULY 7, 2016 (SAN ANTONIO, TX) bioAffinity Technologies today announced that William Bauta, Ph.D., will join the company in September 2016 as Senior Vice President for Research and Development, Therapeutics. Dr. Bauta will direct the development and commercialization...
by Maria Zannes | Jun 23, 2016 | Press Releases
JUNE 23, 2016 (SAN ANTONIO, TX ) bioAffinity Technologies today announced the formation of OncoSelect Therapeutics, LLC, a subsidiary company that will leverage bioAffinity’s proprietary porphyrin-based diagnostic technology to target a variety of cancers for...
by Maria Zannes | May 10, 2016 | Events
May 10, 2016 @2:15 pm- 3:00 pm InnoTech Emerging Medical Technology Symposium Session Two Panelist: Maria Zannes Henry B Gonzalez Convention Center San Antonio, TXUnited States
by Maria Zannes | Apr 16, 2016 | Events
April 16, 2016-April 17, 2016 Presenter: Vivienne Rebel, MD, PhD Associate Professor, Department of Cellular and Structural Biology, Health Science Center in San Antonio, San Antonio, TX, United States of America Abstract: The overall 5-year survival...